Veradigm Other Long-Term Assets 2010-2022 | MDRX
Veradigm other long-term assets from 2010 to 2022. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
| Veradigm Annual Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2022 | $69 |
| 2021 | $897 |
| 2020 | $135 |
| 2019 | $183 |
| 2018 | $181 |
| 2017 | $147 |
| 2016 | $98 |
| 2015 | $360 |
| 2014 | $138 |
| 2013 | $163 |
| 2012 | $50 |
| 2011 | $89 |
| 2010 | $69 |
| 2010 | $10 |
| 2009 | $12 |
| Veradigm Quarterly Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2022-12-31 | $69 |
| 2022-09-30 | $106 |
| 2022-06-30 | $99 |
| 2022-03-31 | $101 |
| 2021-12-31 | $897 |
| 2021-09-30 | $150 |
| 2021-06-30 | $140 |
| 2021-03-31 | $135 |
| 2020-12-31 | $135 |
| 2020-09-30 | $161 |
| 2020-06-30 | $172 |
| 2020-03-31 | $178 |
| 2019-12-31 | $183 |
| 2019-09-30 | $229 |
| 2019-06-30 | $214 |
| 2019-03-31 | $182 |
| 2018-12-31 | $181 |
| 2018-09-30 | $188 |
| 2018-06-30 | $161 |
| 2018-03-31 | $170 |
| 2017-12-31 | $147 |
| 2017-09-30 | $149 |
| 2017-06-30 | $113 |
| 2017-03-31 | $117 |
| 2016-12-31 | $98 |
| 2016-09-30 | $122 |
| 2016-06-30 | $122 |
| 2016-03-31 | $321 |
| 2015-12-31 | $360 |
| 2015-09-30 | $329 |
| 2015-06-30 | $347 |
| 2015-03-31 | $136 |
| 2014-12-31 | $138 |
| 2014-09-30 | $153 |
| 2014-06-30 | $180 |
| 2014-03-31 | $198 |
| 2013-12-31 | $163 |
| 2013-09-30 | $157 |
| 2013-06-30 | $134 |
| 2013-03-31 | $45 |
| 2012-12-31 | $50 |
| 2012-09-30 | $38 |
| 2012-06-30 | $74 |
| 2012-03-31 | $75 |
| 2011-12-31 | $89 |
| 2011-09-30 | $86 |
| 2011-06-30 | $88 |
| 2011-03-31 | $73 |
| 2010-12-31 | $69 |
| 2010-09-30 | $69 |
| 2010-06-30 | |
| 2010-05-31 | $10 |
| 2010-03-31 | |
| 2010-02-28 | $12 |
| 2009-12-31 | $12 |
| 2009-11-30 | $12 |
| 2009-09-30 | |
| 2009-08-31 | $12 |
| 2009-05-31 | $12 |
| 2009-02-28 | $15 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.547B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.128B | 58.69 |
| Hims & Hers Health (HIMS) | United States | $11.646B | 121.00 |
| Doximity (DOCS) | United States | $11.561B | 53.52 |
| Tempus AI (TEM) | United States | $10.010B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.435B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.842B | 60.03 |
| Hinge Health (HNGE) | United States | $3.739B | 0.00 |
| Privia Health (PRVA) | United States | $2.547B | 174.08 |
| Enovis (ENOV) | United States | $1.826B | 10.18 |
| Phreesia (PHR) | United States | $1.642B | 0.00 |
| Schrodinger (SDGR) | United States | $1.551B | 0.00 |
| 10x Genomics (TXG) | United States | $1.535B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.527B | 0.00 |
| Azenta (AZTA) | United States | $1.475B | 68.57 |
| Evolent Health (EVH) | United States | $1.334B | 113.60 |
| Omnicell (OMCL) | United States | $1.291B | 22.78 |
| Claritev (CTEV) | United States | $0.763B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.582B | 0.00 |
| Standard BioTools (LAB) | United States | $0.475B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.450B | 0.00 |
| Talkspace (TALK) | United States | $0.430B | 128.50 |
| Outset Medical (OM) | United States | $0.333B | 0.00 |
| TruBridge (TBRG) | United States | $0.329B | 731.00 |
| Health Catalyst (HCAT) | United States | $0.269B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.231B | 0.00 |
| CapsoVision (CV) | United States | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.149B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.139B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.122B | 0.00 |
| Pulmonx (LUNG) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.104B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 3.73 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.091B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |